BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Criterion Edge - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Criterion Edge
X-ORIGINAL-URL:https://criterionedge.com
X-WR-CALDESC:Events for Criterion Edge
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240717T120000
DTEND;TZID=America/Chicago:20240717T130000
DTSTAMP:20240815T202522Z
CREATED:20240618T193655Z
LAST-MODIFIED:20240815T202522Z
UID:5811-1721217600-1721221200@criterionedge.com
SUMMARY:Trending Topics: From the AI Act to Orphan Devices\, Key Takeaways from RAPS EU Convergence 2024
DESCRIPTION:Welcome to our new Trending Topics webinar series! Each webinar in this series will present key trending topics\, late-breaking regulatory news and other hot-button topics from medical and in vitro device industry leaders. Tap into the critical conversations that are shaping the future of the MedTech industry and join us as we explore current issues\, trending conversations and decisions impacting the MedTech regulatory space. \nIn this webinar\, we will discuss a few of the key trending topics and issues discussed at the RAPS EU Convergence conference in Berlin. Topics include: \n1. The AI Act and MDR: identify the challenges\, incompatibilities and conflicts that arise from applying both frameworks to AI-based medical devices.\n2. Innovative and Orphan Devices: an expert panel suggests developing MDR special conformity assessment pathways to support the unique regulatory challenges faced by orphan and innovative medical devices.\n3. Notified Body Acknowledge Challenges: from inconsistent opinions to EUDAMED delays\, notified bodies continue to face numerous challenges in the current regulatory landscape. What can be done?\n4. The Impact of “massive procrastination” of MDR and IVDR Dossier Submissions: notified body experts are concerned at the potential constraints to future device availability as applications to the Notified Bodies decline in the wake of deadline extensions.\n5. Updates from the IMDRF Working Groups: review the latest updates to the scope and objectives a broad range of guidance documents on topics ranging from artificial intelligence / machine learning (AI/ML)\, good regulatory review practices\, adverse event (AE) terminology\, quality management systems\, personalized medical devices\, and software as a medical device\, and discuss their achievements and challenges. \nWATCH NOW
URL:https://criterionedge.com/event/trending-topics-from-the-ai-act-to-orphan-devices-key-takeaways-from-raps-eu-convergence-2024/
LOCATION:Webinar\, United States
ATTACH;FMTTYPE=image/png:https://criterionedge.com/wp-content/uploads/July-17-2024.png
ORGANIZER;CN="Criterion Edge":MAILTO:support@criterionedge.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240731T120000
DTEND;TZID=America/Chicago:20240731T130000
DTSTAMP:20240815T202124Z
CREATED:20240708T164629Z
LAST-MODIFIED:20240815T202124Z
UID:6193-1722427200-1722430800@criterionedge.com
SUMMARY:Pharma in Focus: The Role of Real-World Evidence (RWE) in Regulatory Submissions
DESCRIPTION:In this webinar\, we will explore the strategic use of Real-World Evidence (RWE) throughout product development. Participants will learn about the integration of RWE from various sources and how it can be used to bolster regulatory submissions. \nLearning Objectives: \n\nUnderstand the sources of Real-World Data (RWD) which are used to generate RWE\nExplore the main uses of RWE throughout the development[SG1]  process\nIdentify strengths and pitfalls when using RWE in regulatory submissions\n\nWATCH NOW
URL:https://criterionedge.com/event/pharma-in-focus-the-role-of-real-world-evidence-rwe-in-regulatory-submissions/
LOCATION:Webinar\, United States
ATTACH;FMTTYPE=image/png:https://criterionedge.com/wp-content/uploads/July-31-2024-v2.png
ORGANIZER;CN="Criterion Edge":MAILTO:support@criterionedge.com
END:VEVENT
END:VCALENDAR